Nadia Gomez, MD
Obstetrics & Gynecology · Las Vegas, NVNPI 1033379276
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $32,290 of the $44,691 with a category attached, or 72.3%. 35 manufacturers reported payments, led by Virtual Incision Corporation at 44.6% of the total. Among obstetrics & gynecology clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $310.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Virtual Incision Corporation$20K
- Arthrex$15K
- Medtronic$3K
- Covidien LP$749
- Intuitive Surgical$735
- Activ Surgical, Inc.$685
- plus $4K from 29 others
What the payments were for
- Consulting fees$32,29072%
- Speaking & faculty fees$4001%
- Travel & lodging$4,42610%
- Food & beverage$7,37016%
- Education$1810%
- Gifts$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Virtual Incision Corporation | 11 | $19,951 |
| Arthrex | 17 | $15,288 |
| Medtronic(2 entities) | 31 | $3,128 |
| Covidien LP | 2 | $749 |
| Intuitive Surgical | 5 | $735 |
| Activ Surgical, Inc. | 4 | $685 |
| Hologic Sales And Service, LLC | 13 | $486 |
| Bayer | 4 | $442 |
| AbbVie(2 entities) | 8 | $372 |
| Axonics, Inc. | 4 | $332 |
| Boston Scientific | 4 | $322 |
| Astellas Pharma US Inc | 9 | $310 |
| Pacira Pharmaceuticals Incorporated | 2 | $234 |
| Coloplast | 3 | $206 |
| Asensus Surgical, Inc. | 1 | $166 |
| Caldera Medical, Inc | 1 | $160 |
| Daiichi Sankyo Inc. | 1 | $156 |
| Applied Medical Resources Corporation | 1 | $129 |
| Pfizer | 1 | $115 |
| Johnson & Johnson | 4 | $100 |
| Mentor Worldwide LLC | 3 | $91 |
| Myovant Sciences Inc. | 1 | $87 |
| Biodelivery Sciences International, Inc. | 1 | $73 |
| Momentis Surgical Inc. | 1 | $64 |
| Collegium Pharmaceutical, Inc. | 1 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Meditrina | 1 | $35 |
| KARL Storz Endoscopy-america | 1 | $32 |
| Novo Nordisk | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Roche Diagnostics Corporation | 1 | $14 |
| Monaghan Medical Corporation | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $11 |
| Agile Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mira!$19,846
- INTERSTIM$1,237
- LigaSure$740
- ActivSight$645
- Da Vinci Surgical System$609
- ALTAVIVA$485
- Kyleena$400
- Bulkamid$263
- GelPOINT V-Path$258
- EXPAREL$234
- Senhance Surgical Robotics System$166
- Desara$160
- Enhertu$156
- Solyx SIS System$154
- Axonics r-SNM System$147
- ARTHREX$146
- UPSYLON$143
- Orilissa$124
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$116
- ALTIS$107
How this compares
$44,691 in reported general payments places this provider in the 95th percentile of 308 obstetrics & gynecology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 35 | $18,774 |
| GemtesaVibegron | 11 | $6,190 |
| Estradiol | 36 | $2,064 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $112 |
| Gabapentin | 14 | $36 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $310 | $18,77435 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $36 | $6,19011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 308 obstetrics & gynecology providers in Nevada.
Other obstetrics & gynecology in Las Vegas
- Darin SwainstonLas Vegas$713K
- Christina KushnirLas Vegas$502K
- Lamarr TylerLas Vegas$170K
- Ralph VennartLas Vegas$144K
- Kenneth VolkerLas Vegas$126K
- Navkaran SinghLas Vegas$104K
- Sunwook KimLas Vegas$94K
- Luis Lopez BenitezLas Vegas$89K
- Linda TranLas Vegas$72K
- Raul Romero JosephLas Vegas$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.